Evidence & IP
We share reported validation, intellectual property, and grant milestones with clear limits. Investors and research partners should consider the underlying methods and records alongside each headline claim.
SIPL reports 91% agreement with clinician-rated HAM-D across 500+ assessments in a clinical validation collaboration with ABVIMS and Dr. RML Hospital, New Delhi. Agreement is a reported validation metric, not a claim of diagnostic accuracy. Study design, cohort details, and limitations should be reviewed alongside the headline figure.
SIPL reports published Indian Patent No. 202511025669 and a WIPO PCT application in process. Patent scope, ownership, jurisdiction, and current status should be confirmed through the relevant patent records during diligence.
SIPL reports a ₹50L+ equity-free award through Grand Challenges India GCE-III, supported by BIRAC, DBT, and the Bill & Melinda Gates Foundation. Grant support is not itself evidence of clinical performance or commercial adoption.
A public bibliography and detailed validation protocol are not listed on this page. For supporting records, methodology, and current IP documentation, please contact SIPL.
Request supporting information